Supernus Pharmaceuticals, Inc. (SUPN)
43.74
-0.45
(-1.02%)
USD |
NASDAQ |
Aug 28, 16:00
43.76
+0.02
(+0.05%)
After-Hours: 19:26
Supernus Pharmaceuticals Cash from Operations (Quarterly) : -4.81M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.81M |
| March 31, 2026 | 66.52M |
| December 31, 2025 | 19.86M |
| September 30, 2025 | -61.66M |
| June 30, 2025 | 58.54M |
| March 31, 2025 | 30.60M |
| December 31, 2024 | 44.41M |
| September 30, 2024 | 53.52M |
| June 30, 2024 | 35.62M |
| March 31, 2024 | 38.40M |
| December 31, 2023 | 44.96M |
| September 30, 2023 | 35.88M |
| June 30, 2023 | -18.87M |
| March 31, 2023 | 49.13M |
| December 31, 2022 | 27.56M |
| September 30, 2022 | 13.84M |
| June 30, 2022 | 71.12M |
| March 31, 2022 | 4.302M |
| December 31, 2021 | 48.76M |
| September 30, 2021 | -4.11M |
| June 30, 2021 | 46.27M |
| March 31, 2021 | 36.20M |
| December 31, 2020 | 31.93M |
| September 30, 2020 | 5.599M |
| June 30, 2020 | 91.95M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.916M |
| December 31, 2019 | 43.79M |
| September 30, 2019 | 37.66M |
| June 30, 2019 | 28.69M |
| March 31, 2019 | 32.99M |
| December 31, 2018 | 32.85M |
| September 30, 2018 | 62.45M |
| June 30, 2018 | 6.556M |
| March 31, 2018 | 27.13M |
| December 31, 2017 | 36.34M |
| September 30, 2017 | 39.00M |
| June 30, 2017 | 25.94M |
| March 31, 2017 | 13.36M |
| December 31, 2016 | 24.94M |
| September 30, 2016 | 28.24M |
| June 30, 2016 | 16.78M |
| March 31, 2016 | -3.142M |
| December 31, 2015 | 22.34M |
| September 30, 2015 | -0.523M |
| June 30, 2015 | 12.98M |
| March 31, 2015 | -0.265M |
| December 31, 2014 | 6.994M |
| September 30, 2014 | 26.78M |
| June 30, 2014 | -6.94M |
| March 31, 2014 | -19.10M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 228.52M |
| Pfizer Inc. | 835.00M |
| Amphastar Pharmaceuticals, Inc. | 51.32M |
| Collegium Pharmaceutical, Inc. | 71.32M |
| Bristol Myers Squibb Co. | 3.393B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 7.094M |
| Cash from Financing (Quarterly) | -7.20M |
| Free Cash Flow | 18.79M |
| Free Cash Flow Per Share (Quarterly) | -0.0926 |
| Free Cash Flow to Equity (Quarterly) | -4.645M |
| Free Cash Flow to Firm (Quarterly) | -3.034M |
| Free Cash Flow Yield | 0.75% |